Clinical trial · Observational
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
NCT00580463CI-TRIAL-00002144completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to collect samples of brain or spine tumors. Memorial Sloan-Kettering Cancer Center would then store them for use by researchers who study brain or spine cancer and try to find better ways of treating it. We will also collect blood and spinal fluid from patients with brain or spine tumors. The blood and spinal fluids are also used for research studies of cancer and its treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Primary or Metastatic Central Nervous System (CNS) Tumor | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To establish a repository of CNS tumors or metastases to the CNS and related tissues for current or future studies.
- timeFrame
- conclusion of the study
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * For acquisition of intra-operative brain or spine tumor specimens, blood specimens and spinal fluid specimens, all patients who undergo surgery for resection or biopsy qualify for inclusion in this protocol. * If spinal fluid is not accessed as part of the operative procedure, it will not be collected. * All patients must be under the care of one or more members of the MSKCC CNS disease management team at the time of tissue acquisition. Patients may have been previously diagnosed and/or treated at another institution. * Subjects are eligible regardless of sex, age or race. * Parental or guardian consents will be obtained in the case of minors (less than 18 years of age) Exclusion Criteria: * Patients or their guardians, in case of a minor, may choose to be excluded at any time. * If a patient, or guardian, decides to withdraw after some or all of the tissues have been collected, such tissues will be destroyed at their request. * Patients or their guardians will be counseled at the time of obtaining their consent, of the possibility of withdrawing from the protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.